Sign inJoin waitlistJoin the waitlist

Shuchi Gulati

Hematology & Oncology · Regents of the Univ of Ca

Credentials: · ·

History

University of Cincinnati College of Medicine
2019–2020
University of Cincinnati College of Medicine
2015–2018
The Reading Hospital and Medical Center
2010–2012
Cleveland Clinic at Fairview Hospital
2009–2010
Dr. Rajendra Prasad Medical College
2005

Research

Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma
Clinical Cancer Research · 2022 · 178 citations
Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition
Journal for ImmunoTherapy of Cancer · 2022 · 71 citations
Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19
JAMA Oncology · 2023 · 43 citations

Trisha Wise-Draper
13 papers · 3 as a fellow
Primo Lara
9 papers
Rana McKay
8 papers
Toni Choueiri
8 papers
Chris Labaki
7 papers
Clara Hwang
6 papers
Jeremy Warner
6 papers
Sumanta Pal
6 papers
Vinita Takiar
6 papers
MP
Matthew Puc
5 papers
Tian Zhang
5 papers
Ben Hinrichs
4 papers

Grants

Combination of Transcriptomic and Metallomic Biomarkers for Risk Assessment in Locoregional Clear Cell Renal Cell Carcinoma
National Cancer Institute · K08
Contact PI · $1.3M · University of California at Davis
2022–2027

Clinical trials

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2025–2037
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Site PI · Recruiting · Phase 3
SWOG Cancer Research Network
2021–2033